Penumbra PEN
NYSE PEN
$319.80 +0.54 (+0.17%)
As of: Sep 9, 2026 · 12:53 PM EDT

Penumbra (PEN) Research & Development (2014 - 2026)

Penumbra's (PEN) quarterly Research & Development came in at $25.4 million in Q2 2026, up 9.38% year-over-year from $23.2 million in Q2 2025, and up 13.47% quarter-over-quarter from $22.4 million in Q1 2026.

Analysis

Penumbra (PEN) Research & Development (2014 - 2026) Analysis & Trends

Penumbra (PEN) has reported Research & Development for 13 consecutive years, with $25.4 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Research & Development rose 9.38% year-over-year to $25.4 million in Q2 2026; TTM through Jun 2026 was $92.2 million, a 1.92% increase from a year earlier, with the FY2025 full-year figure at $89.8 million, down 5.29% from the prior year.
  • Research & Development was $25.4 million for Q2 2026 at Penumbra, up from $22.4 million in the prior quarter.
  • Over five years, Research & Development peaked at $25.4 million in Q2 2026 and troughed at $18.0 million in Q4 2022.
  • A 5-year average of $22.0 million and a median of $21.9 million in 2023 frame the typical range for Research & Development.
  • The widest YoY moves for Research & Development: up 27.41% in 2022, down 65.46% in 2022.
  • Over 5 years, Research & Development stood at $18.0 million in 2022, then advanced by 22.14% to $21.9 million in 2023, then declined by 8.81% to $20.0 million in 2024, then grew by 8.92% to $21.8 million in 2025, then gained by 16.53% to $25.4 million in 2026.
  • The last three Research & Development figures came in at $25.4 million (Q2 2026), $22.4 million (Q1 2026), and $21.8 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Abbott Laboratories 183.86 Bn 178.25 Bn 7.27 Bn 892.00 Mn
2 Intuitive Surgical 124.18 Bn 118.97 Bn 1.96 Bn 370.60 Mn
3 Medtronic 118.18 Bn 109.36 Bn 6.34 Bn 771.00 Mn
4 Stryker 104.54 Bn 101.07 Bn 4.50 Bn 434.00 Mn
5 Boston Scientific 66.34 Bn 65.80 Bn 3.85 Bn 554.00 Mn
6 Edwards Lifesciences 49.64 Bn 45.39 Bn 1.35 Bn 278.90 Mn
7 Alcon 33.93 Bn 32.47 Bn 1.68 Bn -663.00 Mn
8 Dexcom 32.20 Bn 30.25 Bn 830.00 Mn 153.00 Mn
9 Steris 21.14 Bn 20.66 Bn 684.20 Mn 28.60 Mn
10 Penumbra 12.58 Bn 11.92 Bn 264.94 Mn 25.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.40 Mn
Mar 31, 2026 22.38 Mn
Dec 31, 2025 21.79 Mn
Sep 30, 2025 22.68 Mn
Jun 30, 2025 23.22 Mn
Mar 31, 2025 22.08 Mn
Dec 31, 2024 20.01 Mn
Sep 30, 2024 25.21 Mn
Jun 30, 2024 24.94 Mn
Mar 31, 2024 24.63 Mn
Dec 31, 2023 21.94 Mn
Sep 30, 2023 20.96 Mn
Jun 30, 2023 21.54 Mn
Mar 31, 2023 19.99 Mn
Dec 31, 2022 17.96 Mn
Sep 30, 2022 21.32 Mn
Jun 30, 2022 19.56 Mn
Mar 31, 2022 20.56 Mn
Dec 31, 2021 52.00 Mn
Sep 30, 2021 16.73 Mn